Indications

• Neurological Rehabilitation of C and D phases in patients with e.g. hypoxic brain damage, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, craniocerebral injury, critical neuro- and myopathies and Guillain-Barré-Strohl syndrome, cerebral vasculitis, state following cerebral venous and sinus thrombosis.
• Status following meningitis and encephalitis
• Parkinson's disease and other movement disorders (dystonia, Huntington's chorea, ataxia)
• Patients with a dysphagia that requires supervision, a tracheostomy needing aspiration or behavioral and orientation disorder that requires supervision
• Status following surgeries of space-occupying processes in the spinal cord or the brain
• Neurotraumatological sequelae (state following craniocerebral injury II III.0, state following spinal injury)
• Neurodegenerative diseases (incipient dementia, motor neuron diseases)
• Polyneuropathy
• Muscle diseases
• Functional neurological disorders
• Patients with negative Barthel Index
• Care for patients with PEG
• State following surgery of intracranial vessels and vessels leading to the brain
• Encephalomyelitis disseminata (multiple sclerosis)
• Intensive medical rehabilitation with weaning off oxygen (weaning)
• Patients with artificial hearts with neurological symptoms